We found that in OLDA-treated CML cells, no increase in the expression levels of ATG12–ATG5 complex was evident, supporting that the execution of autophagy is not stimulated (Figure 3A). This evidence concerns the gene ATG5 and chronic myelogenous leukemia, BCR-ABL1 positive.